Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
3D models of human ERα and ERβ complexed with coumestrol.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Laquinimod Phase IIa Study in Active Crohn's Disease
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Copolymer 1 inhibits manifestations of graft rejection.
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Multiple sclerosis and progressive resistance training: a systematic review.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Alerting Network Dysfunction in Early Multiple Sclerosis.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Anejaculatory infertility due to multiple sclerosis.
Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Pediatric multiple sclerosis.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Novel therapies for memory cells in autoimmune diseases.

Pages